Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria

Simple item page
dc.contributor.authorOnoja AB
dc.contributor.authorAdeniji AJ
dc.date.accessioned2022-07-26T11:50:18Z
dc.date.available2022-07-26T11:50:18Z
dc.date.issued2013
dc.descriptionInternational Journal of Infectious Diseases
dc.description.abstractSummary Objectives We investigated the antibody level of children against wild measles virus in view of recurrent measles epidemics, in order to provide information on immunization status for health policies and for the global measles mortality reduction initiative. Methods Two hundred and seventy-three children between the ages of 10 months and 13 years were recruited for this study from three hospital facilities in south-west and north-central Nigeria. Serum samples were collected from February to July 2009, and laboratory examination commenced in August of the same year. Measles hemagglutinin (HA) antigen was prepared by culturing the measles vaccine virus strain (Edmonston-Zagreb) in a vero/hSLAM cell line. Serum samples were treated to get rid of potentiating factors, non-specific inhibitors, and agglutinins before the HA/hemagglutination inhibition (HI) procedure. Results Out of the 175 children vaccinated in Ibadan, 60 (34.3%) had an antibody level not sufficient to protect against measles infection. Likewise, 12 (25.0%) vaccinated children from Ilorin had an antibody level not sufficient to protect against measles infection. There was no significant difference in the level of protection between the children in Ibadan and Ilorin (p>0.05). The geometric mean titer (GMT) was 53.83 for males and 48.64 for females. There was no significant difference between the GMTs of females and males in both locations (p>0.05). Also, no significant difference was observed in the GMTs of children in both locations (p>0.05). Conclusions Of the vaccinated children, 157 (57.5%) developed protective measles virus HI antibody, which is not enough to maintain protective herd immunity. Hence there is a need for catch-up and follow-up vaccination programs, especially in rural areas and places with difficult terrains, in order to reduce measles mortality.
dc.identifier.citation10.1016/j.ijid.2013.02.001
dc.identifier.issn1201-9712
dc.identifier.urihttps://nerd.ethesis.ng/handle/123456789/257
dc.language.isoen
dc.subjectCatch-up vaccination
dc.subjectImmune status
dc.subjectHerd immunity
dc.subjectHemagglutination inhibiting antibody
dc.subjectMeasles epidemic
dc.titleKinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Kinetics-of-measles-antibody-by-hemagglutination-in_2013_International-Journ.pdf
Size:
238.48 KB
Format:
Adobe Portable Document Format
Download
Collections
Journal Article